v3.26.1
Immaterial Restatement of Prior Period Financial Statements (Tables)
3 Months Ended
Mar. 31, 2026
Prior Period Adjustment [Abstract]  
Schedule of Audited Condensed Consolidated Balance Sheet
Audited Condensed Consolidated Balance Sheet            
in thousands  December 31, 2025
Previously Reported
   Adjustments   December 31, 2025
As Corrected
 
ASSETS            
Prepaid expenses and other current assets  $59   $(11)  $48 
Note receivable – related party   4,167    (4,167)   
 
Total current assets   17,404    (4,179)   13,226 
Total assets  $26,670   $(4,179)  $22,491 
LIABILITIES AND STOCKHOLDERS’ DEFICIT               
Additional paid-in capital  $
-
   $(2,329)  $(2,329)
Accumulated deficit   (676,957)   (1,850)   (678,807)
Total members’ deficit   (650,689)   (4,179)   (654,868)
Total liabilities and members’ deficit  $26,670   $(4,179)  $22,491 
Schedule of Unaudited Condensed Consolidated Statements of Operations Unaudited Condensed Consolidated Statements of Operations
Unaudited Condensed Consolidated Statements of Operations        
in thousands  March 31, 2025
Previously Reported
   Adjustments   March 31, 2025
As Corrected
 
General and administrative expenses(1)  $1,851   $827   $2,678 
Loss from operations   (1,975)   (827)   (2,802)
Provision for credit losses   (1,310)   840    (470)
Total other expense, net   (16,035)   840    (15,195)
Loss before income taxes   (18,010)   13    (17,996)
Net loss  $(18,010)  $13   $(17,996)
Schedule of Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity
   Additional Paid-in Capital   Accumulated Deficit   Total Stockholders’ Equity 
As Previously Reported            
Balance, December 31, 2024  $
   $(58,962)  $(49,374)
Net loss  $
   $(18,009)  $(18,009)
Balance March 31, 2025  $
   $(76,971)  $(66,134)
                
Adjustments               
Balance, December 31, 2024  $261   $(1,931)  $(1,625)
Investor loan advances and deemed contributions  $(853)  $
   $(853)
Net loss  $
   $13   $13 
Balance March 31, 2025  $(592)  $(1,918)  $(2,465)
                
As Corrected               
Balance, December 31, 2024  $261   $(60,893)  $(51,000)
Investor loan advances and deemed contributions   (853)   
    (853)
Net loss   
    (17,996)   (17,996)
Balance March 31, 2025  $(592)  $(78,889)  $(68,599)
Schedule of Unaudited Condensed Consolidated Statement of Cash Flows
Unaudited Condensed Consolidated Statement of Cash Flows        
in thousands  March 31, 2025
Previously Reported
   Adjustments   March 31, 2025
As Corrected
 
Cash flows from operating activities:            
Net loss  $(18,010)  $13   $(17,996)
Allowance for credit losses   1,310    (840)   470 
Investor expenses incurred on behalf of Company   
    827    827 
Net cash used in operating activities   (2,063)   
    (2,063)
Cash flows from investing activities:               
Advance — note receivable related parties   (1,680)   1,680    
 
Net cash used in investing activities   (2,154)   1,680    (474)
Cash flows from financing activities:               
Constructive disbursements to related party   
    (1,680)   (1,680)
Net cash provided by financing activities   5,335    (1,680)   3,655